Cardiovascular Toxicology

Scope & Guideline

Transforming toxicological knowledge into cardiovascular solutions.

Introduction

Immerse yourself in the scholarly insights of Cardiovascular Toxicology with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1530-7905
PublisherHUMANA PRESS INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2001 to 2024
AbbreviationCARDIOVASC TOXICOL / Cardiovasc. Toxicol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512

Aims and Scopes

The journal 'Cardiovascular Toxicology' primarily focuses on the intersection of cardiovascular health and toxicological research. It aims to publish innovative studies that explore the mechanisms, effects, and therapeutic interventions related to cardiotoxicity caused by various environmental factors, drugs, and diseases. The research methodologies employed include experimental studies, systematic reviews, and clinical investigations.
  1. Cardiotoxicity Mechanisms:
    Research investigating the molecular and cellular mechanisms underlying cardiotoxicity, particularly those induced by chemotherapeutic agents, environmental toxins, and other pharmacological agents.
  2. Therapeutic Interventions:
    Studies focusing on potential protective strategies and therapeutic approaches to mitigate cardiotoxic effects, including the evaluation of natural compounds, pharmacological agents, and lifestyle interventions.
  3. Environmental and Occupational Health:
    Exploration of the impact of environmental pollutants and occupational exposures on cardiovascular health, including studies on heavy metals, particulate matter, and other toxic substances.
  4. Genetic and Epigenetic Factors:
    Research examining the role of genetic predispositions and epigenetic modifications in susceptibility to cardiotoxicity and cardiovascular diseases.
  5. Innovative Diagnostic Tools:
    Development and validation of novel diagnostic methods, including biomarkers and imaging techniques, for early detection and prediction of cardiotoxicity in various patient populations.
The journal has identified several trending and emerging themes that reflect the evolving landscape of cardiovascular toxicology. These areas highlight innovative research directions and increasing relevance to contemporary health challenges.
  1. Nanoparticle Toxicology:
    Research into the cardiotoxic effects of nanoparticles and their protective strategies is gaining momentum, driven by the increasing use of nanotechnology in medicine and environmental applications.
  2. Role of Circular RNAs and Non-coding RNAs:
    Emerging studies are focusing on the role of circular RNAs and other non-coding RNAs in modulating cardiotoxic responses, indicating a growing interest in the regulatory mechanisms of gene expression in cardiovascular health.
  3. Impact of Lifestyle Factors:
    There is an increasing focus on how lifestyle interventions, such as diet, exercise, and fasting, can mitigate cardiotoxicity, reflecting a holistic approach to cardiovascular health.
  4. Integrative Approaches to Cardiotoxicity:
    The integration of multi-omics technologies (genomics, proteomics, metabolomics) to study cardiotoxicity is trending, allowing for a comprehensive understanding of interactions at various biological levels.
  5. Machine Learning in Predicting Cardiotoxicity:
    The application of machine learning algorithms to predict cardiotoxic outcomes is an emerging theme, showing the journal's commitment to incorporating advanced computational methods in cardiovascular research.

Declining or Waning

In contrast to its expanding focus areas, the journal has seen a decline in certain themes that were previously prevalent in its publications. These waning scopes reflect shifts in research priorities and emerging trends in cardiovascular toxicology.
  1. Traditional Cardiovascular Pharmacology:
    Research on classic cardiovascular drugs and their toxicological profiles has decreased, possibly due to a shift towards more contemporary therapeutic agents and innovative drug classes.
  2. Animal Models of Cardiotoxicity:
    While still relevant, studies exclusively using traditional animal models for cardiotoxicity assessment appear to be declining, as researchers increasingly adopt advanced in vitro techniques and humanized models.
  3. Generalized Toxicology Studies:
    Broad toxicological assessments that do not specifically address cardiovascular implications are less frequently published, indicating a more focused approach on cardiovascular-specific toxicological research.
  4. Epidemiological Studies Without Mechanistic Insight:
    Epidemiological research that lacks a mechanistic understanding of cardiovascular toxicity is becoming less common, as the field emphasizes studies that elucidate underlying biological processes.

Similar Journals

Toxicology Research

Connecting researchers to critical toxicological insights.
Publisher: OXFORD UNIV PRESSISSN: 2045-452XFrequency: 6 issues/year

Toxicology Research is a distinguished journal dedicated to advancing the field of toxicology through the dissemination of high-quality research. Published by Oxford University Press, this UK-based journal focuses on critical aspects of toxicology and mutagenesis, highlighting both environmental and pharmacological implications. With an ISSN of 2045-452X and an E-ISSN of 2045-4538, it serves as a valuable resource for researchers, professionals, and students alike. Currently categorized in the Q3 quartile for Health, Toxicology and Mutagenesis, as well as Toxicology in 2023, Toxicology Research maintains a visible presence in Scopus rankings, positioning itself within the targeted professional community. Although the journal operates without open access options, its importance in contributing to scientific discussions and policy formation is undeniable. Covering content from 2012 to 2024, it continues to provide insights into contemporary toxicological challenges, thereby fostering interdisciplinary collaborations and informing best practices in health and safety.

Cardio-Oncology

Pioneering Insights: Where Cardiology Meets Oncology
Publisher: BMCISSN: Frequency: 1 issue/year

Cardio-Oncology, published by BMC since 2015, serves as a premier open-access journal dedicated to the intersection of cardiology and oncology, ensuring that vital research reaches a global audience without barriers. With an impactful presence in the United Kingdom and an impressive Q1 ranking in Cardiology and Cardiovascular Medicine, alongside a Q2 ranking in Oncology as of 2023, the journal captures the growing importance of managing cardiovascular health in cancer patients. Aimed at researchers, healthcare professionals, and students, Cardio-Oncology publishes high-quality research, reviews, and clinical studies that advance understanding in this critical field, fostering an interdisciplinary dialogue essential for improving patient outcomes. Accessible and relevant, the journal reflects the concerted effort to bridge gaps in knowledge and address the complexities faced by healthcare providers managing the dual challenges of cancer and cardiovascular disease.

ARCHIVES OF TOXICOLOGY

Leading the Charge in Toxicology Innovation
Publisher: SPRINGER HEIDELBERGISSN: 0340-5761Frequency: 12 issues/year

ARCHIVES OF TOXICOLOGY is a prestigious journal published by Springer Heidelberg, dedicated to advancing research in the field of toxicology and related disciplines. With a distinguished history dating back to 1930, this journal has continuously provided vital insights and groundbreaking studies, making it a cornerstone in the areas of health, toxicology, and medicine. Recognized for its high impact, it occupies a top-ranking position in Scopus, with remarkable quartile placements in 2023, categorizing it as Q1 in Health, Toxicology and Mutagenesis, and Q1 in Medicine (Miscellaneous). The journal highlights critical research and innovative methodologies, appealing to a diverse audience of researchers, professionals, and students committed to understanding the complexities of toxic substances and their implications for public health and environmental safety. The journal does not currently offer open access, allowing for a more traditional but rigorous peer-review process that ensures the quality and integrity of every published article. Join the global discourse in toxicological science with ARCHIVES OF TOXICOLOGY, where every contribution furthers the understanding of safety and toxicity in our world.

Frontiers in Toxicology

Navigating the Frontiers of Toxicological Discovery
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Toxicology, published by Frontiers Media SA, is a prominent open-access journal dedicated to advancing the understanding of toxicological science. Established in 2019, it serves as a vital forum for innovative research, offering insights into the pharmacological impacts and toxicological profiles of various substances. With its international reach based in Switzerland, this journal has quickly ascended in the academic community, achieving a notable Q1 ranking in Pharmacology, Toxicology and Pharmaceutics (Miscellaneous) and a Q2 ranking in Toxicology as of 2023. The journal is indexed in Scopus, where it ranks #8 out of 43 in its primary category, underscoring its influence and relevance in the field. The scope encompasses cutting-edge studies on the mechanisms of toxicity, including both human and environmental impacts, making it an essential resource for researchers, professionals, and students alike. By promoting open access to high-quality research, Frontiers in Toxicology plays a crucial role in enhancing knowledge sharing and fostering collaboration across disciplines.

ENVIRONMENTAL TOXICOLOGY

Connecting Science and Policy for Environmental Health
Publisher: WILEYISSN: 1520-4081Frequency: 12 issues/year

ENVIRONMENTAL TOXICOLOGY, published by Wiley, is a premier academic journal dedicated to the multifaceted study of toxic substances in the environment and their effects on human health and ecosystems. With the ISSN 1520-4081 and E-ISSN 1522-7278, this journal holds a prestigious position in the field, being ranked in the Q1 category across various relevant disciplines, including Health, Toxicology and Mutagenesis, and Management, Monitoring, Policy and Law. The journal regularly publishes high-quality research articles, reviews, and policy discussions aimed at understanding the implications of environmental toxins from 1980 to the present, contributing to the body of knowledge critical for the safety and sustainability of our environment. Researchers and professionals will find a treasure trove of information that not only highlights current trends and methodologies but also sets the stage for future advancements in toxicology. As a key resource, it provides valuable insights necessary for policy-making, environmental management, and public health, reinforcing its significance in the ever-evolving fields of toxicology and environmental science.

CARDIOVASCULAR RESEARCH

Unveiling the future of heart health research.
Publisher: OXFORD UNIV PRESSISSN: 0008-6363Frequency: 18 issues/year

CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.

TOXICOLOGY MECHANISMS AND METHODS

Pioneering the future of toxicological science.
Publisher: TAYLOR & FRANCIS LTDISSN: 1537-6516Frequency: 9 issues/year

TOXICOLOGY MECHANISMS AND METHODS is a distinguished peer-reviewed journal dedicated to the advancement of toxicological research, published by Taylor & Francis Ltd. With its ISSN 1537-6516 and E-ISSN 1537-6524, this esteemed journal features critical studies and innovative methodologies in the field of toxicology, aligning with its mission to enhance understanding of biological mechanisms and risk assessment. The journal holds a commendable Q2 ranking in both the Health, Toxicology and Mutagenesis, and Toxicology categories, as well as strong positions in Scopus rankings, reflecting its influence with a 71st percentile rank in Toxicology and a 69th percentile rank in Environmental Health. Researchers, professionals, and students in the toxicology domain will find this journal to be an invaluable resource, offering open access options that foster widespread dissemination of its findings. Since its inception, encompassing converged years from 1991 to 1995 and from 2002 to 2024, the journal remains at the forefront of critical discourse and innovative research methods, making it a vital platform for advancing toxicological science globally.

TOXICOLOGY AND INDUSTRIAL HEALTH

Pioneering research at the intersection of health and industry.
Publisher: SAGE PUBLICATIONS INCISSN: 0748-2337Frequency: 12 issues/year

TOXICOLOGY AND INDUSTRIAL HEALTH, published by SAGE PUBLICATIONS INC, is a premier journal in the field of toxicology, public health, and environmental health, with a significant history dating back to 1985. With its ISSN 0748-2337 and E-ISSN 1477-0393, the journal provides a platform for disseminating groundbreaking research and comprehensive reviews that address the complexities of toxic substances in industrial and occupational settings. Despite its Q3 ranking among peers in health, toxicology, and public health, this journal is becoming increasingly influential, reflected in its growing citation metrics. Researchers and professionals benefit from its commitment to fostering knowledge in both theoretical and practical contexts, making it an essential resource for those dedicated to advancing understanding in this vital field. The journal's main objectives include promoting research addressing the implications of toxicology on health and safety standards across industries, ensuring accessibility to current studies for a global audience. Overall, TOXICOLOGY AND INDUSTRIAL HEALTH plays a critical role in bridging the gap between research and real-world applications, proving invaluable to students, professionals, and researchers alike in their pursuit of enhancing public health and environmental safety.

TOXICOLOGY AND APPLIED PHARMACOLOGY

Navigating the Nexus of Safety and Efficacy
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0041-008XFrequency: 24 issues/year

TOXICOLOGY AND APPLIED PHARMACOLOGY, published by Academic Press, Inc. Elsevier Science, stands as a leading journal in the domains of toxicology and pharmacology, with its establishment dating back to 1959. With an impact factor reflecting its academic rigor and relevance, this journal is classified in the Q2 quartile for both pharmacology and toxicology categories, underscoring its significance in the scientific community. It ranks #34 out of 133 in Toxicology and #95 out of 313 in Pharmacology according to Scopus, placing it within the 74th and 69th percentiles, respectively. The journal aims to disseminate quality research that drives advancements in understanding the interactions of drugs and toxic substances within biological systems. Researchers and professionals are invited to contribute and engage with a broad spectrum of articles that cover mechanistic studies, risk assessment, and innovative therapeutic strategies. Although the journal does not offer open access, it continues to be a crucial resource for those who seek to navigate the complex interface of drugs and their toxicological implications.

TOXICOLOGICAL SCIENCES

Pioneering Insights in Toxicological Research
Publisher: OXFORD UNIV PRESSISSN: 1096-6080Frequency: 12 issues/year

TOXICOLOGICAL SCIENCES, published by Oxford University Press, is a premier journal in the field of toxicology that has been a cornerstone of scientific discourse since its inception in 1981. With an impressive 2023 impact factor and ranked in the Q1 category for Toxicology, this journal is highly regarded among researchers, professionals, and students dedicated to pharmacology and toxicology. The journal is committed to advancing the understanding of toxicological science, covering a breadth of topics that include the mechanisms of toxicity, risk assessment, and the regulatory aspects affecting public health. With an ISSN of 1096-6080 and an E-ISSN of 1096-0929, TOXICOLOGICAL SCIENCES facilitates open access scholarly work, ensuring that critical research reaches a global audience and promotes collaborative learning. As it converges towards 2024, the journal remains pivotal in shaping the future of toxicology research, providing insights that are essential for developing safer chemicals and protecting environmental health.